Catalyst Pharma Partners Win Extension to Regain Compliance with NASDAQ … – Benzinga
|
Catalyst Pharma Partners Win Extension to Regain Compliance with NASDAQ …
Benzinga Catalyst Pharmaceutical Partners, Inc. (Nasdaq: CPRX), a specialty pharmaceutical company focused on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, announced today … |
